Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

External beam radiation therapy (EBRT) for asymptomatic bone metastases in patients with solid tumors reduces the risk of skeletal-related events (SREs).

Shulman RM, Meyer JE, Li T, Howell KJ.

Ann Palliat Med. 2018 Nov 6. pii: apm.2018.10.04. doi: 10.21037/apm.2018.10.04. [Epub ahead of print]

2.

Predictive Value of Leukocyte- and Platelet-Derived Ratios in Rectal Adenocarcinoma.

Ward WH, Goel N, Ruth KJ, Esposito AC, Lambreton F, Sigurdson ER, Meyer JE, Farma JM.

J Surg Res. 2018 Dec;232:275-282. doi: 10.1016/j.jss.2018.06.060. Epub 2018 Jul 14.

PMID:
30463730
3.

Concurrent chemoradiation for resected gall bladder cancers and cholangiocarcinomas.

Fareed MM, DeMora L, Esnaola NF, Denlinger CS, Karachristos A, Ross EE, Hoffman J, Meyer JE.

J Gastrointest Oncol. 2018 Aug;9(4):762-768. doi: 10.21037/jgo.2018.05.09.

4.

Dose Escalation in Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Meta-Analysis.

Zaorsky NG, Lehrer EJ, Handorf E, Meyer JE.

Am J Clin Oncol. 2019 Jan;42(1):46-55. doi: 10.1097/COC.0000000000000472.

PMID:
29965809
5.

Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704.

Regine WF, Winter K, Abrams RA, Safran H, Kessel IL, Chen Y, Fugazzi JA, Donnelly ED, DiPetrillo TA, Narayan S, Plastaras JP, Gaur R, Delouya G, Suh JH, Meyer JE, Haddock MG, Didolkar MS, Padula GDA, Johnson D, Hoffman JP, Crane CH.

Adv Radiat Oncol. 2018 Feb 9;3(2):154-162. doi: 10.1016/j.adro.2018.01.003. eCollection 2018 Apr-Jun.

6.

Trends in intensity modulated radiation therapy use for locally advanced rectal cancer at National Comprehensive Cancer Network centers.

Reyngold M, Niland J, Ter Veer A, Bekaii-Saab T, Lai L, Meyer JE, Nurkin SJ, Schrag D, Skibber JM, Benson AB, Weiser MR, Crane CH, Goodman KA.

Adv Radiat Oncol. 2017 Oct 12;3(1):34-41. doi: 10.1016/j.adro.2017.10.001. eCollection 2018 Jan-Mar.

7.

Local Control and Toxicity of External Beam Reirradiation With a Pulsed Low-dose-rate Technique.

Lee CT, Dong Y, Li T, Freedman S, Anaokar J, Galloway TJ, Hallman MA, Weiss SE, Hayes SB, Price RA, Ma CMC, Meyer JE.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):959-964. doi: 10.1016/j.ijrobp.2017.12.012. Epub 2017 Dec 23.

PMID:
29485075
8.

Deviations From Standard Chemoradiation Among Early-Stage Anal Cancer Patients.

Churilla TM, DeMora L, Handorf E, Zaorsky NG, Dong Y, Denlinger CS, Sigurdson ER, Meyer JE.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):945-949. doi: 10.1016/j.ijrobp.2017.12.003. Epub 2017 Dec 16. No abstract available.

PMID:
29485073
9.

Mismatch Repair Deficiency Testing in Patients With Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults.

Shaikh T, Handorf EA, Meyer JE, Hall MJ, Esnaola NF.

JAMA Oncol. 2018 Feb 8;4(2):e173580. doi: 10.1001/jamaoncol.2017.3580. Epub 2018 Feb 8.

10.

Optimal Use of Combined Modality Therapy in the Treatment of Esophageal Cancer.

Shaikh T, Meyer JE, Horwitz EM.

Surg Oncol Clin N Am. 2017 Jul;26(3):405-429. doi: 10.1016/j.soc.2017.01.009. Epub 2017 May 11. Review.

PMID:
28576180
11.

Tissue TGF-β expression following conventional radiotherapy and pulsed low-dose-rate radiation.

Meyer JE, Finnberg NK, Chen L, Cvetkovic D, Wang B, Zhou L, Dong Y, Hallman MA, Ma CC, El-Deiry WS.

Cell Cycle. 2017 Jun 18;16(12):1171-1174. doi: 10.1080/15384101.2017.1317418. Epub 2017 May 9.

12.

Splenic irradiation for splenomegaly: A systematic review.

Zaorsky NG, Williams GR, Barta SK, Esnaola NF, Kropf PL, Hayes SB, Meyer JE.

Cancer Treat Rev. 2017 Feb;53:47-52. doi: 10.1016/j.ctrv.2016.11.016. Epub 2016 Dec 22. Review.

PMID:
28063304
13.

Absence of Pathological Proof of Cancer Associated with Improved Outcomes in Early-Stage Lung Cancer.

Shaikh T, Churilla TM, Murphy CT, Zaorsky NG, Haber A, Hallman MA, Meyer JE.

J Thorac Oncol. 2016 Jul;11(7):1112-20. doi: 10.1016/j.jtho.2016.03.024. Epub 2016 Apr 20.

14.

Dosimetric predictors of hematologic toxicity in patients undergoing concurrent gemcitabine-based chemoradiation for localized pancreatic cancer.

Shaikh T, Wang LS, Egleston B, Burki M, Hoffman JP, Cohen SJ, Meyer JE.

Pract Radiat Oncol. 2016 Jul-Aug;6(4):e107-15. doi: 10.1016/j.prro.2015.11.005. Epub 2015 Nov 14.

PMID:
27032572
15.

Risk of radiation pneumonitis in patients receiving taxane-based trimodality therapy for locally advanced esophageal cancer.

Shaikh T, Churilla TM, Monpara P, Scott WJ, Cohen SJ, Meyer JE.

Pract Radiat Oncol. 2016 Nov - Dec;6(6):388-394. doi: 10.1016/j.prro.2016.02.004. Epub 2016 Feb 27.

16.

Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection.

Boland PM, Meyer JE, Berger AC, Cohen SJ, Neuman T, Cooper HS, Olszanski AJ, Davey M, Cheng JD, Lebenthal A, Burtness BA, Scott WJ, Astsaturov IA.

Am J Clin Oncol. 2017 Aug;40(4):393-398. doi: 10.1097/COC.0000000000000171.

17.

In regard to Wu and Vapiwala et al.

Meyer JE, Dilling TJ, Amdur RJ, Strasser JF, Tendulkar R, Lee WR, Jani AB, Elshaikh M, Poppe MM, Takita C, Currey A, Cheng SK, Jagsi R, Kuo JV, Chen AM, Dragun AE, Bradley K, Beriwal S, Smith RP, Chen RC, Rosenzweig K, Kim S, Mehta K.

Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):858-9. doi: 10.1016/j.ijrobp.2015.12.001. No abstract available.

PMID:
26972659
18.

Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma.

Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS.

Cancer. 2016 May 1;122(9):1349-69. doi: 10.1002/cncr.29692. Epub 2016 Jan 22. Review.

19.

Young Age Increases Risk of Lymph Node Positivity in Early-Stage Rectal Cancer.

Meyer JE, Cohen SJ, Ruth KJ, Sigurdson ER, Hall MJ.

J Natl Cancer Inst. 2016 Jan;108(1). doi: 10.1093/jnci/djv284.

20.

What Are Medical Students in the United States Learning About Radiation Oncology? Results of a Multi-Institutional Survey.

Zaorsky NG, Shaikh T, Handorf E, Eastwick G, Hesney A, Scher ED, Jones RT, Showalter TN, Avkshtol V, Rice SR, Horwitz EM, Meyer JE.

Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):235-42. doi: 10.1016/j.ijrobp.2015.10.008. Epub 2015 Oct 9.

PMID:
26684409
21.

Patterns and predictors of failure following tri-modality therapy for locally advanced esophageal cancer.

Shaikh T, Zaki MA, Dominello MM, Handorf E, Konski AA, Cohen SJ, Shields A, Philip P, Meyer JE.

Acta Oncol. 2016;55(3):303-8. doi: 10.3109/0284186X.2015.1110252. Epub 2015 Nov 19.

PMID:
26581671
22.

Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas.

Smaglo BG, Tesfaye A, Halfdanarson TR, Meyer JE, Wang J, Gatalica Z, Reddy S, Arguello D, Boland PM.

Oncotarget. 2015 Dec 22;6(41):43594-604. doi: 10.18632/oncotarget.6202.

23.

Association of treatment factors with surgical outcomes in tri-modality therapy for esophageal cancer.

Shaikh T, Thomay A, Ruth K, Cohen SJ, Meyer JE.

J Surg Oncol. 2015 Nov;112(6):629-33. doi: 10.1002/jso.24060. Epub 2015 Oct 2.

PMID:
26430952
24.

Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer.

Shaikh T, Wang LS, Egleston B, Burki M, Hoffman JP, Cohen SJ, Meyer JE.

Am J Clin Oncol. 2018 Jan;41(1):59-64. doi: 10.1097/COC.0000000000000227.

25.

Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation.

Wang LS, Shaikh T, Handorf EA, Hoffman JP, Cohen SJ, Meyer JE.

Pract Radiat Oncol. 2015 Sep-Oct;5(5):e457-e463. doi: 10.1016/j.prro.2015.04.004. Epub 2015 Jun 12.

26.

Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer.

Konski A, Meyer JE, Joiner M, Hall MJ, Philip P, Shields A, McSpadden E, Choi M, Adaire B, Duncan G, Meropol NJ, Cescon TP, Cohen SJ.

Radiother Oncol. 2014 Oct;113(1):35-40. doi: 10.1016/j.radonc.2014.08.014. Epub 2014 Oct 20.

PMID:
25441058
27.

Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.

Shaikh T, Ruth K, Scott WJ, Burtness BA, Cohen SJ, Konski AA, Cooper HS, Astsaturov I, Meyer JE.

Ann Thorac Surg. 2015 Jan;99(1):270-6. doi: 10.1016/j.athoracsur.2014.08.033. Epub 2014 Nov 18.

28.

Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial results.

Hurwitz MD, Ghanouni P, Kanaev SV, Iozeffi D, Gianfelice D, Fennessy FM, Kuten A, Meyer JE, LeBlang SD, Roberts A, Choi J, Larner JM, Napoli A, Turkevich VG, Inbar Y, Tempany CM, Pfeffer RM.

J Natl Cancer Inst. 2014 Apr 23;106(5). pii: dju082. doi: 10.1093/jnci/dju082.

29.

Women at increased risk for cardiac toxicity following chemoradiation therapy for esophageal carcinoma.

Tait LM, Meyer JE, McSpadden E, Cheng JD, Baciewicz FA, Meropol NJ, Cohen SJ, Wozniak AJ, Choi M, Konski AA.

Pract Radiat Oncol. 2013 Oct-Dec;3(4):e149-55. doi: 10.1016/j.prro.2013.02.001. Epub 2013 Mar 13.

PMID:
24674412
30.

Neoadjuvant chemoradiation and duration of chemotherapy before surgical resection for pancreatic cancer: does time interval between radiotherapy and surgery matter?

Chen KT, Devarajan K, Milestone BN, Cooper HS, Denlinger C, Cohen SJ, Meyer JE, Hoffman JP.

Ann Surg Oncol. 2014 Feb;21(2):662-9. doi: 10.1245/s10434-013-3396-5. Epub 2013 Nov 26.

PMID:
24276638
31.

HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer.

Meyer JE, Panico VJ, Marconato HM, Sherr DL, Christos P, Pirog EC.

J Gastrointest Cancer. 2013 Dec;44(4):450-5. doi: 10.1007/s12029-013-9543-1.

32.

Impact of preoperative therapy on patterns of recurrence in pancreatic cancer.

Papavasiliou P, Hoffman JP, Cohen SJ, Meyer JE, Watson JC, Chun YS.

HPB (Oxford). 2014 Jan;16(1):34-9. doi: 10.1111/hpb.12058. Epub 2013 Feb 20.

33.

Increasing incidence of rectal cancer in patients aged younger than 40 years: an analysis of the surveillance, epidemiology, and end results database.

Meyer JE, Narang T, Schnoll-Sussman FH, Pochapin MB, Christos PJ, Sherr DL.

Cancer. 2010 Sep 15;116(18):4354-9. doi: 10.1002/cncr.25432.

34.

When less is more, when less is less: local excision in early rectal cancer.

Meyer JE, Sherr DL.

Gastrointest Cancer Res. 2009 May;3(3):123-4. No abstract available.

35.

Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.

Stessin AM, Meyer JE, Sherr DL.

Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1128-33. doi: 10.1016/j.ijrobp.2008.02.065. Epub 2008 Jun 4.

PMID:
18538501

Supplemental Content

Loading ...
Support Center